Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marshall M. Siegel is active.

Publication


Featured researches published by Marshall M. Siegel.


Journal of Bacteriology | 2002

Further Evidence that a Cell Wall Precursor [C55-MurNAc-(Peptide)-GlcNAc] Serves as an Acceptor in a Sorting Reaction

Alexey Ruzin; Anatoly Severin; Frank Ritacco; Keiko Tabei; Guy Singh; Patricia A. Bradford; Marshall M. Siegel; Steven J. Projan; David M. Shlaes

Previous studies suggested that a Gly-containing branch of cell wall precursor [C(55)-MurNAc-(peptide)-GlcNAc], which is often referred to as lipid II, might serve as a nucleophilic acceptor in sortase-catalyzed anchoring of surface proteins in Staphylococcus aureus. To test this hypothesis, we first simplified the procedure for in vitro biosynthesis of Gly-containing lipid II by using branched UDP-MurNAc-hexapeptide isolated from the cytoplasm of Streptomyces spp. Second, we designed a thin-layer chromatography-based assay in which the mobility of branched but not linear lipid II is shifted in the presence of both sortase and LPSTG-containing peptide. These results and those of additional experiments presented in this study further suggest that lipid II indeed serves as a natural substrate in a sorting reaction.


Journal of Mass Spectrometry | 1997

Polysulfated Carbohydrates Analyzed as Ion‐paired Complexes with Basic Peptides and Proteins Using Electrospray Negative Ionization Mass Spectrometry

Marshall M. Siegel; Keiko Tabei; Michael Z. Kagan; Ioncho R. Vlahov; Ronald E. Hileman; Robert J. Linhardt

Electrospray ionization mass spectrometry was used in the negative ion mode to analyze complexes of sucrose octasulfate, sucrose heptasulfate and sulfated alpha-, beta- and gamma-cyclodextrins with synthetically prepared basic peptides, the basic protein ubiquitin and polyamines. The spectra presented demonstrate that complexes with these basic molecules facilitate the analysis of these polysulfated oligosaccharides. Stable (1:1) complexes result from the ion pairing between the protonated basic arginine and lysine residues of the peptide and the anionic sulfate groups of the polysulfated oligosaccharides. Fragmentation of the polysulfated oligosaccharides resulting in the loss of SO3 could be suppressed by controlling the experimental conditions, such as the nozzle-skimmer voltage, used to obtain the spectra. In the absence of fragmentation, it was possible to obtain data on the purity of sucrose octasulfate and sucrose heptasulfate as well as the distribution of the sulfated cyclodextrins. The confounding presence of sodium counter-ions is also eliminated using this method. Complete chemical sulfation of oligosaccharides is difficult to achieve. Thus, data on sample purity are essential for the characterization of sulfated oligosaccharides used as pharmaceutical agents.


Journal of Biological Chemistry | 2014

Interleukin 1/Toll-Like Receptor Induced Autophosphorylation Activates Interleukin 1 Receptor-Associated Kinase 4 and Controls Cytokine Induction in a Cell-Type Specific Manner

Leah Cushing; Wayne Stochaj; Marshall M. Siegel; Robert M. Czerwinski; Ken Dower; Quentin Wright; Margaret Hirschfield; Jean-Laurent Casanova; Capucine Picard; Anne Puel; Lih-Ling Lin; Vikram R. Rao

Background: IRAK4 is a central kinase in IL-1R/TLR signaling. Results: IRAK4 is activated by autophosphorylation, and its inhibition reduces cytokine induction in human monocytes but not dermal fibroblasts. Conclusion: IL-1R/TLR-induced autophosphorylation activates IRAK4 and controls cytokine induction in a cell type-specific manner. Significance: Our data provide the mechanism of IRAK4 activation and role in cytokine induction in human cells. IRAK4 is a central kinase in innate immunity, but the role of its kinase activity is controversial. The mechanism of activation for IRAK4 is currently unknown, and little is known about the role of IRAK4 kinase in cytokine production, particularly in different human cell types. We show IRAK4 autophosphorylation occurs by an intermolecular reaction and that autophosphorylation is required for full catalytic activity of the kinase. Phosphorylation of any two of the residues Thr-342, Thr-345, and Ser-346 is required for full activity, and the death domain regulates the activation of IRAK4. Using antibodies against activated IRAK4, we demonstrate that IRAK4 becomes phosphorylated in human cells following stimulation by IL-1R and Toll-like receptor agonists, which can be blocked pharmacologically by a dual inhibitor of IRAK4 and IRAK1. Interestingly, in dermal fibroblasts, although complete inhibition of IRAK4 kinase activity does not inhibit IL-1-induced IL-6 production, NF-κB, or MAPK activation, there is complete ablation of these processes in IRAK4-deficient cells. In contrast, the inhibition of IRAK kinase activity in primary human monocytes reduces R848-induced IL-6 production with minimal effect on NF-κB or MAPK activation. Taken together, these studies define the mechanism of IRAK4 activation and highlight the differential role of IRAK4 kinase activity in different human cell types as well as the distinct roles IRAK4 scaffolding and kinase functions play.


Biochemistry | 2009

Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.

Laura Lin; Robert M. Czerwinski; Kerry Kelleher; Marshall M. Siegel; Paul Wu; Ron Kriz; Ann Aulabaugh; Mark Stahl

Brutons tyrosine kinase (Btk) plays a central role in signal transduction pathways regulating survival, activation, proliferation, and differentiation of B-lineage lymphoid cells. A number of cell signaling studies clearly show that Btk is activated by Lyn, a Src family kinase, through phosphorylation on activation loop tyrosine 551 (Y(551)). However, the detailed molecular mechanism regulating Btk activation remains unclear. In particular, we do not fully understand the correlation of kinase activity with Y(551) phosphorylation, and the role of the noncatalytic domains of Btk in the activation process. Insect cell expressed full-length Btk is enzymatically active, but a truncated version of Btk, composed of only the kinase catalytic domain, is largely inactive. Further characterization of both forms of Btk by mass spectrometry showed partial phosphorylation of Y(551) of the full-length enzyme and none of the truncated kinase domain. To determine whether the lack of activity of the kinase domain was due to the absence of Y(551) phosphorylation, we developed an in vitro method to generate Y(551) monophosphorylated Btk kinase domain fragment using the Src family kinase Lyn. Detailed kinetic analyses demonstrated that the in vitro phosphorylated Btk kinase domain has a similar activity as the full-length enzyme while the unphosphorylated kinase domain has a very low k(cat) and is largely inactive. A divalent magnesium metal dependence study established that Btk requires a second magnesium ion for activity. Furthermore, our analysis revealed significant differences in the second metal-binding site among the kinase domain and the full-length enzyme that likely account for the difference in their catalytic profile. Taken together, our study provides important mechanistic insights into Btk kinase activity and phosphorylation-mediated regulation.


Journal of The Chemical Society, Chemical Communications | 1989

Direct biochemical nitration in the biosynthesis of dioxapyrrolomycin. A unique mechanism for the introduction of nitro groups in microbial products

Guy T. Carter; Jeanne A. Nietsche; Joseph J. Goodman; Margaret Jennings Torrey; Theresa S. Dunne; Marshall M. Siegel; Donald B. Borders

The nitro group of dioxapyrrolomycin (1) was shown to be introduced via direct biochemical nitration in cultures of the producing organism Streptomyces fumanus containing K15N18O3 as the sole source of nitrogen; the nitro group of dioxapyrrolomycin produced under these conditions contained the same ratio of 18O to 15N as was present in the labelled nitrate precursor, the extent of 18O enrichment of the nitro group being determined by negative electron impact mass spectrometry and 15N n.m.r. spectroscopy.


High Throughput Analysis for Early Drug Discovery | 2004

High Throughput Flow Injection Analysis-Mass Spectrometry for Combinatorial Chemistry Using Electrospray Ionization, Atmospheric Pressure Chemical Ionization and Exact-Mass Fourier Transform Mass Spectrometry

Craig S. Truebenbach; Hui Tong; Nelson Huang; Paul D. Schnier; Marshall M. Siegel

Publisher Summary Mass spectrometry (MS) using atmospheric pressure ionization methods is a powerful tool for obtaining molecular weight (MW) information of samples in a high throughput fashion. It is ideal to characterize the large number of samples produced using combinatorial chemistry synthesis technologies. This chapter presents a report that illustrates an extension of the flow-injection technique for very high sample throughput utilizing a multisprayer ESI source (MUX) consisting of eight parallel sprayers for sequential ESI–MS data acquisition for the analysis of samples prepared in a 384-well plate format. It describes customized software for data processing and reporting of the MUX data. It also describes a modification of the MUX source for atmospheric pressure chemical ionization–mass spectrometry (APCI–MS) for the analysis of less polar samples produced using combinatorial chemistry synthesis technologies. The use of ESI Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS or FTMS) for high-resolution exact-mass measurements of combinatorial chemistry samples, using automated high throughput data acquisition and data analysis modules, is used for confirming the elemental compositions of proposed structures with mass errors less than 0.5 ppm. This chapter closes with the description of a simple and efficient technique for cleaving compounds from combinatorial chemistry beads that is compatible with direct ESI mass spectral analysis.


Journal of Mass Spectrometry | 2009

Structure characterization of lipocyclopeptide antibiotics, aspartocins A, B & C, by ESI-MSMS and ESI-nozzle-skimmer-MSMS.

Marshall M. Siegel; Fangming Kong; Xidong Feng; Guy T. Carter

Three lipocyclopeptide antibiotics, aspartocins A (1), B (2), and C (3), were obtained from the aspartocin complex by HPLC separation methodology. Their structures were elucidated using previously published chemical degradation results coupled with spectroscopic studies including ESI-MS, ESI-Nozzle Skimmer-MSMS and NMR. All three aspartocin compounds share the same cyclic decapeptide core of cyclo [Dab2 (Asp1-FA)-Pip3-MeAsp4-Asp5-Gly6-Asp7-Gly8-Dab9-Val10-Pro11]. They differ only in the fatty acid side chain moiety (FA) corresponding to (Z)-13-methyltetradec-3-ene-carbonyl, (+,Z)-12-methyltetradec-3-ene-carbonyl and (Z)-12-methyltridec-3-ene-carbonyl for aspartocins A (1), B (2), and C (3), respectively. All of the sequence ions were observed by ESI-MSMS of the doubly charged parent ions. However, a number of the sequence ions observed were of low abundance. To fully sequence the lipocyclopeptide antibiotic structures, these low abundance sequence ions together with complementary sequence ions were confirmed by ESI-Nozzle-Skimmer-MSMS of the singly charged linear peptide parent fragment ions H-Asp5-Gly6-Asp7-Gly8-Dab9-Val10-Pro11-Dab2(1+)-Asp1-FA. Cyclization of the aspartocins was demonstrated to occur via the beta-amino group of Dab2 from ions of moderate intensity in the ESI-MSMS spectra. As the fatty acid moieties do not undergo internal fragmentations under the experimental ESI mass spectral conditions used, the 14 Da mass difference between the fatty acid moieties of aspartocins A (1) and B (2) versus aspartocin C (3) was used as an internal mass tag to differentiate fragment ions containing fatty acid moieties and those not containing the fatty acid moieties. The most numerous and abundant fragment ions observed in the tandem mass spectra are due to the cleavage of the tertiary nitrogen amide of the pipecolic acid residue-3 (16 fragment ions) and the proline residue-11 (7 fragment ions). In addition, the neutral loss of ethanimine from alpha,beta-diaminobutyric acid residue 9 was observed for the parent molecular ion and for 7 fragment ions.


Journal of the American Chemical Society | 2002

Structures of the Muraymycins, Novel Peptidoglycan Biosynthesis Inhibitors

Leonard A. McDonald; Laurel R. Barbieri; Guy T. Carter; Eileen Lenoy; Jason A. Lotvin; Peter J. Petersen; Marshall M. Siegel; Guy Singh; R. Thomas Williamson


Journal of the American Chemical Society | 1992

Calicheamicins, a novel family of antitumor antibiotics. 4. Structure elucidation of calicheamicins .beta.1Br, .gamma.1Br, .alpha.2I, .alpha.3I, .beta.1I, .gamma.1I, and .delta.1I

May D. Lee; Theresa S. Dunne; Conway C. Chang; Marshall M. Siegel; George O. Morton; George A. Ellestad; William J. McGahren; Donald B. Borders


Journal of Medicinal Chemistry | 2005

2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.

Allan Wissner; M. Brawner Floyd; Bernard D. Johnson; Heidi L. Fraser; Charles Ingalls; Thomas Nittoli; Russell Dushin; Carolyn Discafani; Ramaswamy Nilakantan; Joseph Marini; Malini Ravi; Kinwang Cheung; Xingzhi Tan; Sylvia Musto; Tami Annable; Marshall M. Siegel; Frank Loganzo

Collaboration


Dive into the Marshall M. Siegel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fangming Kong

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge